Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 1, 2010, Pages 20-23

  Martin, Stanley I ^a   Wellington, Linda ^a   Stevenson, Kurt B ^a   Mangino, Julie E ^a   Sai Sudhakar, Chittoor B ^a   Firstenberg, Michael S ^a   Blais, Danielle ^a   Sun, Benjamin C ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Circulatory assist device; Infection and obesity; Left ventricular assist device

Indexed keywords

ADULT; AGED; ARTICLE; ASPERGILLUS; BACTERIUM DETECTION; BODY MASS; CANDIDA; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; HEART ASSIST DEVICE; HUMAN; INFECTION RISK; LEFT VENTRICULAR ASSIST DEVICE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; ADOLESCENT; CHI SQUARE DISTRIBUTION; COMPLICATION; EQUIPMENT DESIGN; MICROBIOLOGY; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; SURGICAL WOUND INFECTION; TIME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; EQUIPMENT DESIGN; FEMALE; HEART-ASSIST DEVICES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; OHIO; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS; YOUNG ADULT;

EID: 77954555808     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.227801     Document Type: Article

References (13)

1. Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano RJ Jr, Moazami N. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007;84:515-520.
2. Chinn R, Dembitsky W, Eaton L, Chillcott S, Stahovich M, Rasmusson B, Pagani F. Multicenter experience: prevention and management of left ventricular assist device infections. Asaio J 2005;51:461-470.
3. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A, Trenholme G. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005;40:1108-1115.
4. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003;163:2146-2148.
5. Russo PL, Spelman DW. A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2002;23:372-376.
6. Lu JC, Grayson AD, Jha P, Srinivasan AK, Fabri BM. Risk factors for sternal wound infection and mid-term survival following coronary artery bypass surgery. Eur J Cardiothorac Surg 2003;23:943-949.
7. Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, Martin R, Edmonds D, Cocks J, Greenbough J, Lowe J, Randle L, Castell J, Browne E, Bellis K, Aberline M. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2004;25:472-476.
8. Butler J, Howser R, Portner PM, Pierson RN 3rd. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 2005;79:66-73.
9. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
10. Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. Jama 2008;300:2398-2406.
11. Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006;7:473-480.
12. Drews T, Jurmann M, Michael D, Miralem P, Weng Y, Hetzer R. Differences in pulsatile and non-pulsatile mechanical circulatory support in long-term use. J Heart Lung Transplant 2008;27:1096-1101.
13. Shuhaiber J, Hur K, Gibbons R. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation? J Card Surg 2009;24:250-255.